Antiangiogenic Inhibitors |
|
Cat. No. |
Product |
Activity |
5121 |
3PO |
PFKFB3 inhibitor;
antiangiogenic |
5617 |
AZD 1480 |
Potent and
selective JAK2 inhibitor; antiangiogenic |
4706 |
Borrelidin |
Antiangiogenic;
inhibits threonyl-tRNA synthetase |
5029 |
CHC |
Monocarboxylic acid
transport (MCT) inhibitor; displays anti-angiogenic activities |
1629 |
Herbimycin A |
Antiangiogenic.
Inhibits Src family kinases and Hsp90 |
5981 |
Itraconazole |
SMO antagonist;
antiangiogenic |
5260 |
KG 5 |
Antiangiogenic;
PDGFRβ, B-Raf, c-Raf, FLT3 and KIT inhibitor |
6305 |
Lenalidomide |
Angiogenesis
inhibitor; also TNF-α inhibitor and cereblon binder |
4664 |
Obtustatin |
Potent and
selective α1β1 inhibitor; antiangiogenic |
2710 |
OGT 2115 |
Antiangiogenic.
Heparanase inhibitor |
6302 |
Pomalidomide |
Antiangiogenic;
also TNF-α inhibitor and cereblon ubiquitination inhibitor |
2954 |
PX 12 |
Thioredoxin-1
inhibitor; attenuates expression of HIF-1α |
1418 |
Resveratrol |
Cyclooxygenase
inhbitor |
6187 |
SK 216 |
Angiogenesis
inhibitor; Also PAI-1 inhibitor |
6498 |
TASP 0277308 |
Potent and
selective S1P1 receptor antagonist; inhibits angiogenesis |
0652 |
Thalidomide |
Antiangiogenic;
also inhibits TNF-α synthesis |
1098 |
Tranilast |
Antiangiogenic |
|
|
|
Matrix
Metalloprotease Inhibitors |
|
Cat. No. |
Product |
Activity |
2622 |
ARP 101 |
Inhibitor of MMP-2 |
2961 |
Batimastat |
Potent, broad
spectrum MMP inhibitor |
2632 |
CL 82198
hydrochloride |
Selective inhibitor
of MMP-13 |
3807 |
Disulfiram |
Inhibits expression
of MMP-2 and MMP-9; displays a range of other activities |
4090 |
Doxycycline hyclate |
Broad-spectrum MMP
inhibitor; tetracycline derivative |
2983 |
GM 6001 |
Broad spectrum MMP
inhibitor |
7030 |
GW 280264X |
Potent ADAM10 and
ADAM17 endopeptidase nhibitor |
6439 |
JNJ 0966 |
Pro-MMP9 activation
inhibitor |
2631 |
Marimastat |
Broad spectrum MMP
inhibitor |
3268 |
Minocycline
hydrochloride |
Inhibitor of MMP
activity |
4902 |
NSC 405020 |
Inhibitor of
MT1-MMP; antitumor |
2520 |
PD 166793 |
Broad spectrum MMP
inhibitor |
6088 |
SB 3CT |
High affinity and
selective MMP2 inhibitor |
4775 |
SD 2590
hydrochloride |
Potent MMP
inhibitor |
6134 |
T 26c disodium salt |
Highly potent and
selective MMP13 inhibitor |
5523 |
TAPI 0 |
ADAM-17 (TACE) and
MMP inhibitor |
6162 |
TAPI 1 |
ADAM-17 (TACE) and
MMP inhibitor |
6013 |
TAPI 2 |
ADAM-17 (TACE) and
MMP inhibitor |
2900 |
UK 370106 |
Highly selective
MMP-3 and MMP-12 inhibitor |
4188 |
UK 383367 |
Potent and
selective BMP-1 (PCP) inhibitor |
2633 |
WAY 170523 |
Potent and
selective inhibitor of MMP-13 |
|
|
|
Hypoxia Inducible
Factor (HIF) Inhibitors |
|
Cat. No. |
Product |
Activity |
5953 |
Adaptaquin |
HIF-prolyl
hydroxylase-2 (PHD2) inhibitor; antioxidant |
4705 |
Chetomin |
Blocks interaction
of HIF-1α, HIF-2α and STAT2 with CBP/p300 |
6157 |
cis VH 298 |
Negative control
for VH 298 |
5764 |
Deferoxamine
mesylate |
Hypoxia mimetic;
also iron chelator |
4408 |
DMOG |
Inhibitor of
hypoxia-inducible factor α (HIF-α) prolyl hydroxylase (HIF-PH) |
5520 |
Echinomycin |
Highly potent and
selective HIF-1α inhibitor |
7287 |
FAM-DEALA-Hyp-YIPD |
Fluorescent HIF-1α
peptide |
7452 |
FAM-DEALAHypYIPMDDDFQLRSF |
Fluorescent HIF-1α
peptide |
6653 |
FM19G11 |
HIF α-subunit
inhibitor |
5655 |
GN 44028 |
Potent HIF-1α
inhibitor |
4451 |
IOX 2 |
Potent, selective
HIF-1α prolyl hydroxylase-2 (PHD2) inhibitor |
4324 |
KC7F2 |
HIF-1α inhibitor;
down-regulates HIF-1α protein synthesis |
6322 |
LW 6 |
HIF-1α inhibitor;
inhibits cellular accumulation of HIF-1α; also malate dehydrogenase-2
inhibitor |
2954 |
PX 12 |
Thioredoxin-1
inhibitor; attenuates expression of HIF-1α |
5582 |
TAT-cyclo-CLLFVY |
Selective HIF-1
dimerization inhibitor |
5243 |
TC-S 7009 |
High affinity and
selective HIF-2α inhibitor |
7774 |
VH 032 |
Inhibitor of VHL;
blocks interaction of VHL and HIF-α |
6156 |
VH 298 |
High-affinity
inhibitor of VHL; blocks interaction of VHL and HIF-α |